Skip to content
Clinical Trials – home
Aarhus Universitet
Sponsor

Aarhus Universitet

Denmark Vennelyst Boulevard 4, 8000 Aarhus, Denmark

About the sponsor

The institution demonstrates substantial expertise in developing and applying sophisticated magnetic resonance imaging techniques for cardiovascular evaluation. Research initiatives focus on utilizing hyperpolarized MRI to assess cardiac metabolism and function in various patient populations, including those with heart failure, atrial fibrillation, and individuals undergoing cardiac procedures. These non-invasive imaging approaches enable real-time visualization of myocardial metabolism and provide insights into cardiac energetics.

  • Hyperpolarized Carbon-13 Pyruvate MRI for Cardiac Metabolic Imaging
  • Cardiac Function Assessment in Atrial Fibrillation and Heart Failure
  • Metabolic Evaluation in Patients Undergoing Cardiac Ablation
  • Myocardial Perfusion and Tissue Characterization

The research extends to examining cardiac remodeling and metabolic changes following interventions such as catheter ablation, with particular attention to understanding the relationship between cardiac structure, function, and metabolic activity in diverse cardiovascular conditions.

About Specializations

Aarhus Universitet runs clinical trials in conditions such as Osteoarthritis, Poisoning, Transient ischaemic attack, Amyotrophic lateral sclerosis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

16 clinical trials

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pyruvic Acid
  • Sponsor:Aarhus Universitet
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pyruvic Acid
  • Sponsor:Aarhus Universitet
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pyruvic Acid
  • Sponsor:Aarhus Universitet
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Aarhus Universitet
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pyruvic Acid
  • Sponsor:Aarhus Universitet

Neoplasm malignant+1

Recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pyruvic Acid
  • Sponsor:Aarhus Universitet
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Gadoteric Acid
  • Sponsor:Aarhus Universitet
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Aarhus Universitet
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alanine
  • Sponsor:Aarhus Universitet
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Paracetamol
  • Sponsor:Aarhus Universitet

Diabetic nephropathy

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Meglumine Gadoterate
  • Sponsor:Aarhus Universitet

Poisoning

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:Nitrous Oxide
  • Sponsor:Aarhus Universitet

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).